Citations 1
Tolvaptan Modifies Patient Risk Class Distribution Over Time in Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Analysis of Data From the TEMPO 3:4 Trial
Japes, Hina, Tracy, LaRee , Mccormick, Linda, Maringer, Katherine, Nourbakhsh, Ali, Dahl, Neera K. , Chebib, Fouad T. , Rahbari-Oskoui, Frederic F. , Jiang, Huan , Perrone, Ronald D. , Nourbakhsh, Ali
Journal of the American Society of Nephrology | May 17, 2024 | Volume: 33 | Issue: 11S | Pages: 161-162
